Table 1 Median enrollment rates of women per different medical conditions examined in the included randomized controlled trials
From: Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis
Medical conditions | Number of trials (%) | Median enrollment rates of women, % (percentiles 25–75) |
|---|---|---|
Viral diseases not including HIV/AIDS | 9 (3) | 42 (31–60) |
HIV/AIDS | 13 (4) | 33 (9–57) |
Bacterial and fungal infections | 24 (8) | 37 (25–49) |
Cardiovascular diseases (overall) | 85 (29) | 39 (25–52) |
Ischemic heart disease | 17 (6) | 22 (17–33) |
Congestive heart failure | 14 (5) | 34 (25–53) |
Stroke | 15 (5) | 41 (34–49) |
Hypertension | 11 (4) | 38 (19–52) |
Digestive system diseases | 26 (9) | 47 (33–54) |
Liver disease | 12 (4) | 35 (26–46) |
Neoplasms | 53 (18) | 39 (28–47) |
Neoplasms not including lung cancer | 44 (15) | 41 (28–48) |
Endocrine system diseases (overall) | 39 (13) | 46 (33–58) |
Diabetes type 1 | 4 (1) | 37 (14–59) |
Diabetes type 2 | 36 (12) | 46 (34–57) |
Respiratory tract diseases | 28 (10) | 39 (20–60) |
Immune system diseases | 12 (4) | 68 (46–81) |